GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Moss Genomics Inc (XCNQ:MOSS) » Definitions » Capex-to-Operating-Cash-Flow

Moss Genomics (XCNQ:MOSS) Capex-to-Operating-Cash-Flow : 0.00 (As of Dec. 2024)


View and export this data going back to 2023. Start your Free Trial

What is Moss Genomics Capex-to-Operating-Cash-Flow?

Capex-to-Operating-Cash-Flow assesses how much of a company’s cash flow from operations is being devoted to capital expenditure. It’s also useful to distinguish whether the company is capital intensive or not.

Moss Genomics's Capital Expenditure for the three months ended in Dec. 2024 was C$0.00 Mil. Its Cash Flow from Operations for the three months ended in Dec. 2024 was C$-0.02 Mil.

GuruFocus do not calculate Capex-to-Operating-Cash-Flow if the Cash Flow from Operations is negative.


Moss Genomics Capex-to-Operating-Cash-Flow Historical Data

The historical data trend for Moss Genomics's Capex-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Moss Genomics Capex-to-Operating-Cash-Flow Chart

Moss Genomics Annual Data
Trend Jun22 Jun23
Capex-to-Operating-Cash-Flow
- -

Moss Genomics Quarterly Data
Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Sep24 Dec24
Capex-to-Operating-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Moss Genomics's Capex-to-Operating-Cash-Flow

For the Health Information Services subindustry, Moss Genomics's Capex-to-Operating-Cash-Flow, along with its competitors' market caps and Capex-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Moss Genomics's Capex-to-Operating-Cash-Flow Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Moss Genomics's Capex-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Moss Genomics's Capex-to-Operating-Cash-Flow falls into.


;
;

Moss Genomics Capex-to-Operating-Cash-Flow Calculation

Moss Genomics's Capex-to-Operating-Cash-Flow for the fiscal year that ended in Jun. 2023 is calculated as

Capex-to-Operating-Cash-Flow=- Capital Expenditure / Cash Flow from Operations
=- (0) / -0.715
=N/A

Moss Genomics's Capex-to-Operating-Cash-Flow for the quarter that ended in Dec. 2024 is calculated as

Capex-to-Operating-Cash-Flow=- Capital Expenditure / Cash Flow from Operations
=- (0) / -0.019
=N/A

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Moss Genomics  (XCNQ:MOSS) Capex-to-Operating-Cash-Flow Explanation

Capex-to-Operating-Cash-Flow ratio assesses how much of a company’s Cash Flow from Operations is being devoted to Capital Expenditure. It is a good indicator in terms of how much the company is focused on growth. In general, a high Capex-to-Operating-Cash-Flow ratio indicates that the company is investing more in physical assets and is focused on growth and expansion. Conversely, lower ratio could indicate that a company has reached maturity and is no longer pursuing aggressive growth.

Moreover, the ratio is also useful to distinguish whether the company is capital intensive or not. If the ratio is large, then the company tends to be capital intensive. Lower ratio suggests that it’s a capital-light business. The ratio can be combined with ROIC % to identify whether the company is an asset-light business that has a high return on invested capital. This is one question investors commonly ask to see if a company qualifies as a good company.


Moss Genomics Capex-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Moss Genomics's Capex-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


Moss Genomics Business Description

Traded in Other Exchanges
Address
1030 West Georgia Street, Suite 908, Vancouver, BC, CAN, V6E 2Y3
Moss Genomics Inc is an emerging consumer genomics company that provides personalized health, anti-aging, and wellness solutions based on genomic, microbiome, and epigenome data. The company aims to eliminate barriers in healthcare by offering accessible, affordable at-home testing along with easy-to-understand actionable results.
Executives
Hunter Jordan Director
Lucas Cahill 10% Security Holder

Moss Genomics Headlines

No Headlines